Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Molecular Cancer Therapeutics|March 1, 2006
Sphingolipid targets in cancer therapyDavid E Modrak, David V Gold, David M GoldenbergInternational Journal of Clinical and Experimental Pathology|January 14, 2011
Enhanced expression of CD74 in gastrointestinal cancers and benign tissuesDavid V Gold, Rhona Stein, Jack Burton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancerDavid V Gold, Keith Schutsky, David Modrak, et al.International Journal of Cancer|January 5, 2002
Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancerThomas M Cardillo, Rosalyn Blumenthal, Zhiliang Ying, et al.Molecular Cancer|November 22, 2013
Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucinDavid V Gold, Guy Newsome, Donglin Liu, et al.Molecular Cancer Research : MCR|June 18, 2009
Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell linesDavid E Modrak, Evelyn Leon, David M Goldenberg, et al.International Journal of Cancer|March 3, 2004
Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograftDavid V Gold, David E Modrak, Keith Schutsky, et al.Oncotarget|January 18, 2015
Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancerDonglin Liu, Chien-Hsing Chang, David V Gold, et al.Archives of Pathology & Laboratory Medicine|January 31, 2014
Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistryChanjuan Shi, Nipun Merchant, Guy Newsome, et al.Human Immunology|April 17, 2012
Evaluation of a non-viral vaccine in smallpox-vaccinated individuals and immunized HLA-transgenic miceAlice P Taylor, Boby Makabi-Panzu, Xiaochuan Chen, et al.Pageof 3